Titre:
  • Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Auteur:Ingle, James N; Tu, D; Pater, Joseph L; Muss, Hyman B; Martino, S; Robert, Nicholas J; Piccart-Gebhart, Martine; Castiglione, Monica; Shepherd, L; Pritchard, Kathleen; Livingston, Robert; Davidson, Nancy E; Norton, Larry; Perez, E A; Abrams, Jeffrey S; Cameron, David A; Palmer, Michael J; Goss, Paul E
Informations sur la publication:Annals of oncology, 19, 5, page (877-882)
Statut de publication:Publié, 2008-05
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Extended adjuvant therapy
Intent-to-treat
Letrozole
MeSH keywords:Antineoplastic Agents -- administration & dosage
Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Hormonal -- therapeutic use
Aromatase Inhibitors -- administration & dosage
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Double-Blind Method
Estrogens
Humans
Kaplan-Meiers Estimate
Lymphatic Metastasis
Neoplasms, Hormone-Dependent -- drug therapy
Neoplasms, Second Primary -- drug therapy
Neoplasms, Second Primary -- epidemiology
Nitriles -- administration & dosage
Nitriles -- therapeutic use
Patient Acceptance of Health Care
Placebos
Postmenopause
Progesterone
Proportional Hazards Models
Recurrence
Tamoxifen -- therapeutic use
Triazoles -- administration & dosage
Triazoles -- therapeutic use
Note générale:Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdm566
info:pii/mdm566
info:scp/43049139182
info:pmid/18332043